We could not detect significant differences in lung 18FLT phosphorylation rate k3 in PAH patients in comparison to the age‐matched healthy controls, nor in unaffected BMPR2 mutation carriers. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.